Skip to main content
Skip to footer

Akari Therapeutics

A Revolution in Treating Autoinflammatory & Orphan Diseases

HOME
ABOUT
- Close
- COMPANY OVERVIEW
- MANAGEMENT
- BOARD OF DIRECTORS
AREAS OF FOCUS
INVESTOR RELATIONS
PRESS
- Close
- PRESS RELEASES
- STORIES
CONTACT US

Main Content

Slide

ADVANCED THERAPIES

FOR AUTOIMMUNE &

INFLAMMATORY DISEASES

CORPORATE PRESENTATION VIEW OUR CORPORATE PRESENTATION

RECENT PRESS RELEASES

Akari Therapeutics Announces Key Leadership Appointments

December 18, 2024

Akari Therapeutics Appoints Torsten Hombeck, Ph.D. as Chief Financial Officer

December 16, 2024

Akari Therapeutics Regains Full Nasdaq Compliance

November 19, 2024

Akari Therapeutics Announces Successful Completion of Merger of Akari Therapeutics and Peak Bio

November 14, 2024

Akari Therapeutics Announces Shareholder Approval in Connection With Peak Bio Inc. Merger

November 8, 2024

Footer

Follow Us

Privacy Statement

Expanded Access

Copyright © 2024 · Akari Therapeutics · Site Designed by Polus Digital, Inc.